Sat Jan 04 16:03:20 UTC 2025: ## HMPV Respiratory Illness Surge in China Sparks Concerns, but No Pandemic Alert Issued

**Beijing, January 2025** – A surge in human metapneumovirus (HMPV) infections in China has raised concerns, particularly given the recent history of the COVID-19 pandemic. While social media is rife with alarming posts, neither the World Health Organization (WHO) nor the Centers for Disease Control and Prevention (CDC) have declared a public health emergency.

The outbreak coincides with the winter season, a time when respiratory illnesses typically peak. HMPV, first discovered in 2001, is affecting individuals of all ages, though those with weakened immune systems, chronic respiratory conditions (like asthma or COPD), infants, young children, and the elderly are at higher risk. Symptoms mimic those of the common cold or flu, including cough, runny nose, fever, and sore throat. In severe cases, pneumonia or bronchitis can develop.

The virus spreads through close contact and respiratory droplets. The CDC recommends preventative measures such as frequent handwashing, avoiding touching the face, and staying home during outbreaks.

While HMPV is not a new virus and is not considered an imminent pandemic threat, experts emphasize that its seasonal resurgence is common. The Indian health ministry is closely monitoring the situation, with Dr. Suresh Gupta of Sir Ganga Ram Hospital stating that HMPV is a known virus causing typically mild, self-limiting illness that rarely requires hospitalization. Most cases respond to over-the-counter medications and rest. Severe cases, however, may necessitate hospitalization for oxygen therapy or intravenous fluids.

Currently, no specific vaccine exists for HMPV. Authorities are urging the public to remain calm and to practice good hygiene to reduce the spread of the virus and other circulating respiratory illnesses, including influenza and COVID-19.

Read More